Peapack Gladstone Financial Corp Biogen Inc. Transaction History

Peapack Gladstone Financial Corp

$6.51 Billion
Q2 2024

A detailed history of Peapack Gladstone Financial Corp transactions in Biogen Inc. stock. As of the latest transaction made, Peapack Gladstone Financial Corp holds 1,885 shares of BIIB stock, worth $327,594. This represents 0.01% of its overall portfolio holdings.

Number of Shares

1,885

Previous 1,884 0.05%

Holding current value

$327,594

Previous $406,000 7.64%

% of portfolio

0.01%

Previous 0.01%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $190 - $236	1 Added 0.05%	1,885 $437,000
Q1 2024 May 10, 2024	SELL	$212.02 - $267.71 $196,966 - $248,702	-929 Reduced 33.03%	1,884 $406,000
Q4 2023 Feb 13, 2024	SELL	$222.59 - $267.94 $31,830 - $38,315	-143 Reduced 4.84%	2,813 $728,000
Q3 2023 Nov 14, 2023	SELL	$253.3 - $285.89 $48,127 - $54,319	-190 Reduced 6.04%	2,956 $759,000
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $20,643 - $23,854	75 Added 2.44%	3,146 $895,000
Q1 2023 May 15, 2023	SELL	$256.56 - $292.34 $6,414 - $7,308	-25 Reduced 0.81%	3,071 $858,000
Q4 2022 Feb 14, 2023	SELL	$252.44 - $306.72 $111,326 - $135,263	-441 Reduced 12.47%	3,096 $857,000
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $55,097 - $75,974	283 Added 8.7%	3,537 $945,000
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $21,567 - $25,647	-115 Reduced 3.41%	3,254 $664,000
Q1 2022 May 16, 2022	SELL	$193.77 - $244.14 $21,314 - $26,855	-110 Reduced 3.16%	3,369 $709,000
Q4 2021 Feb 15, 2022	BUY	$223.92 - $287.77 $10,076 - $12,949	45 Added 1.31%	3,479 $835,000
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $87,160 - $113,667	-308 Reduced 8.23%	3,434 $972,000
Q2 2021 Aug 16, 2021	SELL	$259.0 - $414.71 $6,216 - $9,953	-24 Reduced 0.64%	3,742 $1.3 Million
Q1 2021 May 14, 2021	BUY	$242.95 - $284.63 $292,754 - $342,979	1,205 Added 47.05%	3,766 $1.05 Million
Q4 2020 Feb 16, 2021	SELL	$236.26 - $355.63 $21,972 - $33,073	-93 Reduced 3.5%	2,561 $627,000
Q2 2020 Aug 14, 2020	SELL	$258.66 - $342.55 $6,725 - $8,906	-26 Reduced 0.97%	2,654 $710,000
Q1 2020 May 15, 2020	SELL	$268.85 - $341.04 $15,324 - $19,439	-57 Reduced 2.08%	2,680 $848,000
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $8,582 - $11,858	39 Added 1.45%	2,737 $812,000
Q3 2019 Nov 13, 2019	SELL	$217.44 - $243.88 $73,059 - $81,943	-336 Reduced 11.07%	2,698 $628,000
Q2 2019 Aug 15, 2019	BUY	$219.29 - $241.72 $48,243 - $53,178	220 Added 7.82%	3,034 $710,000
Q1 2019 May 15, 2019	SELL	$216.71 - $338.96 $15,386 - $24,066	-71 Reduced 2.46%	2,814 $665,000
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $8,633 - $10,935	31 Added 1.09%	2,885 $868,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $12,914 - $16,888	44 Added 1.57%	2,854 $1.01 Million
Q2 2018 Aug 09, 2018	SELL	$257.52 - $306.91 $40,945 - $48,798	-159 Reduced 5.36%	2,810 $816,000
Q4 2017 Feb 14, 2018	BUY	$307.64 - $344.58 $57,836 - $64,781	188 Added 6.76%	2,969 $0
Q2 2017 Aug 14, 2017	BUY	N/A	2,781	2,781 $0

Others Institutions Holding BIIB

# of Institutions

1,018

Shares Held

128M

Call Options Held

1.22M

Put Options Held

1.4M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peapack Gladstone Financial Corp, based on Form 13F filings with the SEC.

News

Stay updated on Peapack Gladstone Financial Corp with notifications on news.

Account

Peapack Gladstone Financial Corp Biogen Inc. Transaction History